MyoKardia to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

MyoKardia Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten for Symptomatic, Obstructive Hypertrophic Cardiomyopathy

Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights

CytomX Therapeutics Announces First Quarter 2018 Financial Results

Jounce Therapeutics Reports First Quarter 2018 Financial Results